Aviso Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13M Buy
20,394
+1,016
+5% +$219K 1.75% 15
2026
Q1
$4.21M Buy
19,378
+648
+3% +$144K 1.9% 13
2025
Q4
$4.28M Buy
18,730
+455
+2% +$104K 1.8% 13
2025
Q3
$4.23M Buy
18,275
+494
+3% +$101K 1.84% 13
2025
Q2
$3.3M Buy
17,781
+1,089
+7% +$202K 1.54% 16
2025
Q1
$3.5M Buy
16,692
+2,317
+16% +$450K 1.86% 10
2024
Q4
$2.55M Buy
14,375
+3,719
+35% +$684K 1.3% 13
2024
Q3
$2.1M Sell
10,656
-569
-5% -$106K 1.14% 21
2024
Q2
$1.93M Sell
11,225
-1,499
-12% -$248K 1.14% 17
2024
Q1
$2.32M Buy
12,724
+962
+8% +$166K 1.46% 11
2023
Q4
$1.82M Buy
+11,762
New +$1.71M 1.32% 17

Other funds holding ABBV

Aviso Wealth Management's ABBV Position: Q2 2026 in Review

Aviso Wealth Management increased its AbbVie (ABBV) stake by 5.2% in Q2 2026, buying an estimated $219K and bringing the position to 20,394 shares worth $5.13M. The position accounts for 1.75% of the portfolio, ranked #15.

Aviso Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aviso Wealth Management held 20,394 shares of AbbVie worth $5.13M as of Q2 2026.
  • Aviso Wealth Management bought 1,016 AbbVie shares in Q2 2026, an estimated $219K.
  • AbbVie made up 1.75% of Aviso Wealth Management's portfolio in Q2 2026, its #15 holding.
  • Aviso Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aviso Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.